Td Asset Management Inc Rapt Therapeutics, Inc. Transaction History

Td Asset Management Inc

$107 Billion
Q3 2024

A detailed history of Td Asset Management Inc transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 12,262 shares of RAPT stock, worth $20,477. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,262

Previous 12,262 -0.0%

Holding current value

$20,477

Previous $37,000 35.14%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$6.87 - $26.45 $723,795 - $2.79 Million	-105,356 Reduced 89.57%	12,262 $110,000
Q4 2023 Feb 12, 2024	SELL	$11.28 - $25.46 $406,080 - $916,560	-36,000 Reduced 23.43%	117,618 $2.92 Million
Q3 2023 Oct 27, 2023	BUY	$16.34 - $24.66 $1.01 Million - $1.52 Million	61,831 Added 67.36%	153,618 $2.55 Million
Q2 2023 Aug 09, 2023	SELL	$16.06 - $21.61 $27,318 - $36,758	-1,701 Reduced 1.82%	91,787 $1.72 Million
Q4 2022 Feb 06, 2023	SELL	$16.28 - $24.6 $46,316 - $69,987	-2,845 Reduced 2.95%	93,488 $1.85 Million
Q2 2022 Aug 04, 2022	SELL	$10.26 - $23.59 $17,565 - $40,386	-1,712 Reduced 1.75%	96,333 $1.76 Million
Q1 2022 May 10, 2022	SELL	$17.02 - $40.22 $178,675 - $422,229	-10,498 Reduced 9.67%	98,045 $2.16 Million
Q4 2021 Feb 10, 2022	BUY	$29.5 - $39.5 $734,638 - $983,668	24,903 Added 29.77%	108,543 $3.99 Million
Q3 2021 Nov 09, 2021	BUY	$29.86 - $39.47 $173,188 - $228,926	5,800 Added 7.45%	83,640 $2.6 Million
Q2 2021 Aug 11, 2021	BUY	$17.99 - $40.02 $236,046 - $525,102	13,121 Added 20.27%	77,840 $2.39 Million
Q1 2021 May 14, 2021	BUY	$16.0 - $24.46 $56,912 - $87,004	3,557 Added 5.82%	64,719 $1.44 Million
Q4 2020 Feb 16, 2021	BUY	$15.89 - $40.87 $50,720 - $130,457	3,192 Added 5.51%	61,162 $1.21 Million
Q3 2020 Nov 10, 2020	BUY	$21.6 - $37.5 $673,920 - $1.17 Million	31,200 Added 116.55%	57,970 $1.87 Million
Q2 2020 Aug 13, 2020	BUY	$14.16 - $32.85 $156,779 - $363,715	11,072 Added 70.53%	26,770 $777,000
Q1 2020 May 15, 2020	BUY	$11.86 - $48.86 $33,326 - $137,296	2,810 Added 21.8%	15,698 $334,000
Q4 2019 Feb 11, 2020	BUY	$12.3 - $30.78 $158,522 - $396,692	12,888 New	12,888 $356,000

Others Institutions Holding RAPT

# of Institutions

104

Shares Held

27.1M

Call Options Held

26.7K

Put Options Held

2.4K

View Full List

About RAPT Therapeutics, Inc.

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $49.5M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

More about RAPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Rapt Therapeutics, Inc. Transaction History